allylamine


Also found in: Medical, Wikipedia.

allylamine

[¦al·əl·ə¦mēn]
(organic chemistry)
CH2CHCH2NH2 A yellow oil that is miscible with water; boils at 58°C; prepared from mustard oil.
References in periodicals archive ?
5% to 5%) shampoo, ketoconazole shampoo, clotrimazole, allylamine cream and lotion, propylene glycol 50% in water, nystatin, salicylic acid, cicloproxolamine, tretinoin, lactic acid lotion and 1% diclofenac gel.
Advances made during the 1990s led to the introduction of a new allylamine, terbinafine, for the treatment of dermatophytoses and new lipid formulations of amphotericin B with improved safety profiles.
Terbinafine, in the allylamine class, also inhibits ergosterol biosynthesis, but at a different point in the pathway.
Naftifine is an allylamine drug, and is mainly an antidermatophyte agent --albeit a "very, very potent antidermatophyte" --with no antibacterial activity, she said.
Piras, "Antiproliferative synergism of the allylamine SF 86327 and ketoconazole on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi" Antimicrobial Agents and Chemotherapy, vol.
Tinea corporis on a non-hair-bearing area is readily cleared with a topical azole antifungal agent, such as ketoconazole cream 2% twice daily for 2 weeks or a topical allylamine, such as terbinafine cream 1%, twice daily for 2 weeks.
For this reason, aminolysis reactions of waste PET have been carried out using different amines such as allylamine, morpholine, hydrazine benzylamine, ethylenediamine, hexamethylenediamine, piperidine, aniline, and polyamines (25), (26).
Naftifine hydrochloride (naftifine) is a topical antifungal of the allylamine class, displaying fungicidal and fungistatic activity.
Background and Objective: N-(1-naphthylmethyl)amine is an important intermediate in the synthesis of biologically active compounds, including allylamine fungicides, such as naftifine, terbinafine, and butenafine.
NEW ORLEANS - Naftifine hydrochloride 2% cream, an investigational topical allylamine antifungal, hit all of its primary and secondary end points in a pair of phase III, placebo-controlled clinical trials that were conducted in patients with tinea pedis or tinea cruris.